Sutro Biopharma Ownership 2024 | Who Owns Sutro Biopharma Now?
Institutional Ownership
102.78%
Insider Ownership
0.93%
Retail Ownership
-3.71%
Institutional Holders
122.00
Sutro Biopharma Institutional Shareholders
Institutional Shareholders by % of Total Shares
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| SUVRETTA CAPITAL MANAGEMENT, LLC | 12.54% | 0.83% | 7,708,690 | 1,930,502 | 33.41% | 22,586,462 | Jun 30, 2024 |
| BLACKROCK INC. | 11.24% | 0.00% | 6,910,730 | 1,208,825 | 21.20% | 20,248,438 | Jun 30, 2024 |
| POINT72 ASSET MANAGEMENT, L.P. | 7.24% | 0.03% | 4,447,634 | 4,186,938 | 1606.06% | 13,031,567 | Jun 30, 2024 |
| MILLENNIUM MANAGEMENT LLC | 7.10% | 0.01% | 4,361,893 | -374,070 | -7.90% | 12,780,346 | Jun 30, 2024 |
| VANGUARD GROUP INC | 5.79% | 0.00% | 3,555,340 | 532,550 | 17.62% | 10,417,147 | Jun 30, 2024 |
| BIOIMPACT CAPITAL LLC | 4.95% | 1.39% | 3,043,346 | -1,053,273 | -25.71% | 8,917,004 | Jun 30, 2024 |
| SAMSARA BIOCAPITAL, LLC | 3.57% | 1.35% | 2,196,814 | 521,235 | 31.11% | 6,436,665 | Jun 30, 2024 |
| KYNAM CAPITAL MANAGEMENT, LP | 3.29% | 0.46% | 2,023,683 | 21,956 | 1.10% | 5,929,391 | Jun 30, 2024 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 3.25% | 0.01% | 2,000,000 | - | - | 5,860,000 | Jun 30, 2024 |
| BAILLIE GIFFORD & CO | 3.01% | 0.00% | 1,848,751 | 1,845 | 0.10% | 5,416,840 | Jun 30, 2024 |
| PARKMAN HEALTHCARE PARTNERS LLC | 2.92% | 0.70% | 1,792,740 | 2,689 | 0.15% | 5,252,728 | Jun 30, 2024 |
| EVERSEPT PARTNERS, LP | 2.83% | 0.35% | 1,739,129 | 647,710 | 59.35% | 5,095,648 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 2.81% | 0.00% | 1,724,941 | 438,625 | 34.10% | 5,054,956 | Jun 30, 2024 |
| ACADIAN ASSET MANAGEMENT LLC | 2.56% | 0.01% | 1,574,958 | 370,705 | 30.78% | 4,613,000 | Jun 30, 2024 |
| STATE STREET CORP | 2.55% | 0.00% | 1,565,307 | 368,584 | 30.80% | 4,586,350,000 | Jun 30, 2024 |
| DIMENSIONAL FUND ADVISORS LP | 1.77% | 0.00% | 1,085,281 | -223,603 | -17.08% | 3,179,853 | Jun 30, 2024 |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 1.71% | 0.01% | 1,050,189 | -19,333 | -1.81% | 3,077,054 | Jun 30, 2024 |
| GOLDMAN SACHS GROUP INC | 1.71% | 0.00% | 1,049,372 | 246,637 | 30.72% | 3,074,661 | Jun 30, 2024 |
| PANAGORA ASSET MANAGEMENT INC | 1.48% | 0.01% | 907,503 | 122,299 | 15.58% | 2,658,984 | Jun 30, 2024 |
| NUVEEN ASSET MANAGEMENT, LLC | 1.47% | 0.00% | 905,443 | 567,815 | 168.18% | 2,652,948 | Jun 30, 2024 |
Sutro Biopharma's largest institutional shareholder is SUVRETTA CAPITAL MANAGEMENT, LLC, holding 12.54% of the company's total share outstanding, currently valued at $22.59M. The top 10 institutional shareholders own together 61.99% of the company.
Institutional Shareholders by % of Total Assets
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| AQUILO CAPITAL MANAGEMENT, LLC | 1.24% | 2.15% | 762,498 | -402,968 | -34.58% | 2,234,119 | Jun 30, 2024 |
| BIOIMPACT CAPITAL LLC | 4.95% | 1.39% | 3,043,346 | -1,053,273 | -25.71% | 8,917,004 | Jun 30, 2024 |
| SAMSARA BIOCAPITAL, LLC | 3.57% | 1.35% | 2,196,814 | 521,235 | 31.11% | 6,436,665 | Jun 30, 2024 |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 12.54% | 0.83% | 7,708,690 | 1,930,502 | 33.41% | 22,586,462 | Jun 30, 2024 |
| PARKMAN HEALTHCARE PARTNERS LLC | 2.92% | 0.70% | 1,792,740 | 2,689 | 0.15% | 5,252,728 | Jun 30, 2024 |
| KYNAM CAPITAL MANAGEMENT, LP | 3.29% | 0.46% | 2,023,683 | 21,956 | 1.10% | 5,929,391 | Jun 30, 2024 |
| EVERSEPT PARTNERS, LP | 2.83% | 0.35% | 1,739,129 | 647,710 | 59.35% | 5,095,648 | Jun 30, 2024 |
| DAFNA CAPITAL MANAGEMENT LLC | 0.54% | 0.23% | 329,579 | -4,500 | -1.35% | 965,666 | Jun 30, 2024 |
| TEJARA CAPITAL LTD | 0.33% | 0.22% | 203,145 | 8,727 | 4.49% | 595,215 | Jun 30, 2024 |
| UBS OCONNOR LLC | 0.45% | 0.05% | 275,057 | 20,000 | 7.84% | 805,917 | Jun 30, 2024 |
| GSA CAPITAL PARTNERS LLP | 0.38% | 0.05% | 235,397 | 235,397 | 100.00% | 690,000 | Jun 30, 2024 |
| POINT72 ASSET MANAGEMENT, L.P. | 7.24% | 0.03% | 4,447,634 | 4,186,938 | 1606.06% | 13,031,567 | Jun 30, 2024 |
| CORNERCAP INVESTMENT COUNSEL INC | 0.06% | 0.02% | 35,360 | -330 | -0.92% | 103,605 | Jun 30, 2024 |
| SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC | 0.37% | 0.02% | 225,367 | 98,908 | 78.21% | 660,325 | Jun 30, 2024 |
| ACADIAN ASSET MANAGEMENT LLC | 2.56% | 0.01% | 1,574,958 | 370,705 | 30.78% | 4,613,000 | Jun 30, 2024 |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 0.32% | 0.01% | 195,700 | -80,000 | -29.02% | 573,401 | Jun 30, 2024 |
| PANAGORA ASSET MANAGEMENT INC | 1.48% | 0.01% | 907,503 | 122,299 | 15.58% | 2,658,984 | Jun 30, 2024 |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 1.71% | 0.01% | 1,050,189 | -19,333 | -1.81% | 3,077,054 | Jun 30, 2024 |
| SCHONFELD STRATEGIC ADVISORS LLC | 1.03% | 0.01% | 634,200 | -488,900 | -43.53% | 1,858,206 | Jun 30, 2024 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 3.25% | 0.01% | 2,000,000 | - | - | 5,860,000 | Jun 30, 2024 |
The largest Sutro Biopharma shareholder by % of total assets is AQUILO CAPITAL MANAGEMENT, LLC. The company owns 762.50K shares of Sutro Biopharma (STRO), representing 2.15% of its total assets.
Institutional Buyers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| POINT72 ASSET MANAGEMENT, L.P. | 7.24% | 0.03% | 4,447,634 | 4,186,938 | 1606.06% | 13,031,567 | Jun 30, 2024 |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 12.54% | 0.83% | 7,708,690 | 1,930,502 | 33.41% | 22,586,462 | Jun 30, 2024 |
| BLACKROCK INC. | 11.24% | 0.00% | 6,910,730 | 1,208,825 | 21.20% | 20,248,438 | Jun 30, 2024 |
| EVERSEPT PARTNERS, LP | 2.83% | 0.35% | 1,739,129 | 647,710 | 59.35% | 5,095,648 | Jun 30, 2024 |
| NUVEEN ASSET MANAGEMENT, LLC | 1.47% | 0.00% | 905,443 | 567,815 | 168.18% | 2,652,948 | Jun 30, 2024 |
| VANGUARD GROUP INC | 5.79% | 0.00% | 3,555,340 | 532,550 | 17.62% | 10,417,147 | Jun 30, 2024 |
| SAMSARA BIOCAPITAL, LLC | 3.57% | 1.35% | 2,196,814 | 521,235 | 31.11% | 6,436,665 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 2.81% | 0.00% | 1,724,941 | 438,625 | 34.10% | 5,054,956 | Jun 30, 2024 |
| ACADIAN ASSET MANAGEMENT LLC | 2.56% | 0.01% | 1,574,958 | 370,705 | 30.78% | 4,613,000 | Jun 30, 2024 |
| STATE STREET CORP | 2.55% | 0.00% | 1,565,307 | 368,584 | 30.80% | 4,586,350,000 | Jun 30, 2024 |
| AQR CAPITAL MANAGEMENT LLC | 0.46% | 0.00% | 283,516 | 247,694 | 691.46% | 830,701 | Jun 30, 2024 |
| GOLDMAN SACHS GROUP INC | 1.71% | 0.00% | 1,049,372 | 246,637 | 30.72% | 3,074,661 | Jun 30, 2024 |
| GSA CAPITAL PARTNERS LLP | 0.38% | 0.05% | 235,397 | 235,397 | 100.00% | 690,000 | Jun 30, 2024 |
| RENAISSANCE TECHNOLOGIES LLC | 1.17% | 0.00% | 719,497 | 233,700 | 48.11% | 2,108,126 | Jun 30, 2024 |
| LPL FINANCIAL LLC | 0.37% | 0.00% | 230,149 | 230,149 | 100.00% | 674,337 | Jun 30, 2024 |
| STRS OHIO | 0.27% | 0.00% | 165,300 | 150,300 | 1002.00% | 484,329,000 | Jun 30, 2024 |
| PANAGORA ASSET MANAGEMENT INC | 1.48% | 0.01% | 907,503 | 122,299 | 15.58% | 2,658,984 | Jun 30, 2024 |
| SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC | 0.37% | 0.02% | 225,367 | 98,908 | 78.21% | 660,325 | Jun 30, 2024 |
| FRANKLIN RESOURCES INC | 0.16% | 0.00% | 95,423 | 95,423 | 100.00% | 279,589 | Jun 30, 2024 |
| BANK OF NEW YORK MELLON CORP | 0.44% | 0.00% | 272,719 | 88,034 | 47.67% | 799,067 | Jun 30, 2024 |
As of Jun 30 2024, Sutro Biopharma's largest institutional buyer is POINT72 ASSET MANAGEMENT, L.P.. The company purchased 4.19M stocks of STRO, valued at $13.03M.
Institutional Sellers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| BIOIMPACT CAPITAL LLC | 4.95% | 1.39% | 3,043,346 | -1,053,273 | -25.71% | 8,917,004 | Jun 30, 2024 |
| SCHONFELD STRATEGIC ADVISORS LLC | 1.03% | 0.01% | 634,200 | -488,900 | -43.53% | 1,858,206 | Jun 30, 2024 |
| CANDRIAM S.C.A. | - | - | - | -440,422 | -100.00% | - | Jun 30, 2024 |
| AQUILO CAPITAL MANAGEMENT, LLC | 1.24% | 2.15% | 762,498 | -402,968 | -34.58% | 2,234,119 | Jun 30, 2024 |
| MILLENNIUM MANAGEMENT LLC | 7.10% | 0.01% | 4,361,893 | -374,070 | -7.90% | 12,780,346 | Jun 30, 2024 |
| MORGAN STANLEY | 0.47% | 0.00% | 287,810 | -261,556 | -47.61% | 843,286 | Jun 30, 2024 |
| DIMENSIONAL FUND ADVISORS LP | 1.77% | 0.00% | 1,085,281 | -223,603 | -17.08% | 3,179,853 | Jun 30, 2024 |
| PROPEL BIO MANAGEMENT, LLC | - | - | - | -195,000 | -100.00% | - | Jun 30, 2024 |
| VERITION FUND MANAGEMENT LLC | 0.16% | 0.00% | 97,888 | -185,733 | -65.49% | 286,812 | Jun 30, 2024 |
| CUBIST SYSTEMATIC STRATEGIES, LLC | 0.03% | 0.00% | 16,463 | -177,208 | -91.50% | 48,237 | Jun 30, 2024 |
| SIMPLIFY ASSET MANAGEMENT INC. | - | - | - | -120,000 | -100.00% | - | Jun 30, 2024 |
| D. E. SHAW & CO., INC. | 0.21% | 0.00% | 128,665 | -112,978 | -46.75% | 376,988 | Jun 30, 2024 |
| JUMP FINANCIAL, LLC | - | - | - | -111,197 | -100.00% | - | Jun 30, 2024 |
| BNP PARIBAS ARBITRAGE, SNC | 0.01% | - | 6,372 | -91,855 | -93.51% | 18,670 | Jun 30, 2024 |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 0.32% | 0.01% | 195,700 | -80,000 | -29.02% | 573,401 | Jun 30, 2024 |
| ENTRYPOINT CAPITAL, LLC | - | - | - | -69,678 | -100.00% | - | Jun 30, 2024 |
| LIGHTHOUSE INVESTMENT PARTNERS, LLC | - | - | - | -66,585 | -100.00% | - | Jun 30, 2024 |
| VIRTU FINANCIAL LLC | - | - | - | -63,157 | -100.00% | - | Jun 30, 2024 |
| MAN GROUP PLC | 0.21% | 0.00% | 130,277 | -60,356 | -31.66% | 381,712 | Jun 30, 2024 |
| CHASE INVESTMENT COUNSEL CORP | - | - | - | -57,700 | -100.00% | - | Jun 30, 2024 |
As of Jun 30 2024, Sutro Biopharma's biggest institutional seller is BIOIMPACT CAPITAL LLC. The company sold -1.05M shares of STRO, valued at $8.92M.
Institutional New positions
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| GSA CAPITAL PARTNERS LLP | 0.38% | 0.05% | 235,397 | 235,397 | 100.00% | 690,000 | Jun 30, 2024 |
| LPL FINANCIAL LLC | 0.37% | 0.00% | 230,149 | 230,149 | 100.00% | 674,337 | Jun 30, 2024 |
| QUBE RESEARCH & TECHNOLOGIES LTD | 0.11% | 0.00% | 70,614 | 70,614 | 100.00% | 206,899 | Jun 30, 2024 |
| ALPS ADVISORS INC | 0.10% | 0.00% | 63,785 | 63,785 | 100.00% | 186,890 | Jun 30, 2024 |
| HUDSON BAY CAPITAL MANAGEMENT LP | 0.10% | 0.00% | 60,761 | 60,761 | 100.00% | 178,030 | Jun 30, 2024 |
| COREBRIDGE FINANCIAL, INC. | 0.07% | 0.00% | 44,040 | 44,040 | 100.00% | 129,037 | Jun 30, 2024 |
| NOMURA HOLDINGS INC | 0.07% | 0.00% | 43,426 | 43,426 | 100.00% | 127,239 | Jun 30, 2024 |
| MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 0.05% | 0.00% | 30,913 | 30,913 | 100.00% | 90,575 | Jun 30, 2024 |
| SHERBROOKE PARK ADVISERS LLC | 0.03% | 0.01% | 19,073 | 19,073 | 100.00% | 55,884 | Jun 30, 2024 |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 0.02% | - | 13,661 | 13,661 | 100.00% | 40,000 | Jun 30, 2024 |
| FORVIS WEALTH ADVISORS, LLC | 0.02% | 0.00% | 12,840 | 12,840 | 100.00% | 37,622 | Jun 30, 2024 |
| STATE OF WYOMING | 0.02% | 0.01% | 11,725 | 11,725 | 100.00% | 34,354 | Jun 30, 2024 |
| MEEDER ASSET MANAGEMENT INC | 0.00% | 0.00% | 2,822 | 2,822 | 100.00% | 8,268 | Jun 30, 2024 |
| CWM, LLC | 0.00% | - | 1,546 | 1,546 | 100.00% | 5,000 | Jun 30, 2024 |
| GROUP ONE TRADING, L.P. | 0.00% | - | 1,100 | 1,100 | 100.00% | 3,223,000 | Jun 30, 2024 |
| GEN-WEALTH PARTNERS INC | 0.00% | 0.00% | 1,042 | 1,042 | 100.00% | 3,053 | Jun 30, 2024 |
| SRS CAPITAL ADVISORS, INC. | 0.00% | 0.00% | 657 | 657 | 100.00% | 1,926 | Jun 30, 2024 |
| SIGNATUREFD, LLC | 0.00% | - | 354 | 354 | 100.00% | 1,037 | Jun 30, 2024 |
| PNC FINANCIAL SERVICES GROUP, INC. | 0.00% | - | 51 | 51 | 100.00% | 149 | Jun 30, 2024 |
| ROTHSCHILD INVESTMENT LLC | - | - | 30 | 30 | 100.00% | 88 | Jun 30, 2024 |
Sutro Biopharma's largest new institutional shareholder by number of shares is GSA CAPITAL PARTNERS LLP, purchased 235.40K shares, valued at $690.00K, as of undefined.
Institutional Sold Out
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| CANDRIAM S.C.A. | - | - | - | -440,422 | -100.00% | - | Jun 30, 2024 |
| PROPEL BIO MANAGEMENT, LLC | - | - | - | -195,000 | -100.00% | - | Jun 30, 2024 |
| SIMPLIFY ASSET MANAGEMENT INC. | - | - | - | -120,000 | -100.00% | - | Jun 30, 2024 |
| JUMP FINANCIAL, LLC | - | - | - | -111,197 | -100.00% | - | Jun 30, 2024 |
| ENTRYPOINT CAPITAL, LLC | - | - | - | -69,678 | -100.00% | - | Jun 30, 2024 |
| LIGHTHOUSE INVESTMENT PARTNERS, LLC | - | - | - | -66,585 | -100.00% | - | Jun 30, 2024 |
| VIRTU FINANCIAL LLC | - | - | - | -63,157 | -100.00% | - | Jun 30, 2024 |
| CHASE INVESTMENT COUNSEL CORP | - | - | - | -57,700 | -100.00% | - | Jun 30, 2024 |
| MIRAE ASSET GLOBAL INVESTMENTS CO., LTD. | - | - | - | -44,019 | -100.00% | - | Jun 30, 2024 |
| KENNEDY CAPITAL MANAGEMENT LLC | - | - | - | -30,947 | -100.00% | - | Jun 30, 2024 |
| AMERICAN INTERNATIONAL GROUP, INC. | - | - | - | -30,017 | -100.00% | - | Jun 30, 2024 |
| TWO SIGMA SECURITIES, LLC | - | - | - | -23,291 | -100.00% | - | Jun 30, 2024 |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | - | - | - | -16,925 | -100.00% | - | Jun 30, 2024 |
| LAZARD ASSET MANAGEMENT LLC | - | - | - | -16,386 | -100.00% | - | Jun 30, 2024 |
| HRT FINANCIAL LP | - | - | - | -12,057 | -100.00% | - | Jun 30, 2024 |
| QUANTBOT TECHNOLOGIES LP | - | - | - | -2,100 | -100.00% | - | Jun 30, 2024 |
| METROPOLITAN LIFE INSURANCE CO/NY | - | - | - | -1,632 | -100.00% | - | Jun 30, 2024 |
| ZURCHER KANTONALBANK (ZURICH CANTONALBANK) | - | - | - | -285 | -100.00% | - | Jun 30, 2024 |
| NELSON, VAN DENBURG & CAMPBELL WEALTH MANAGEMENT GROUP, LLC | - | - | - | -13 | -100.00% | - | Jun 30, 2024 |
Sutro Biopharma's largest sold out institutional shareholder by shares sold is CANDRIAM S.C.A., sold -0.44M shares, valued at -, as of undefined.
Sutro Biopharma Mutual Fund Holders
| Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
|---|---|---|---|---|---|
| CORNERCAP GROUP OF FUNDS /VA/ | 0.26% | 18,563 | 5,862 | 46.15% | Sep 30, 2022 |
| FRANKLIN STRATEGIC SERIES | 0.18% | 1,532,638 | - | - | Jan 31, 2024 |
| Federated Hermes MDT Series | 0.13% | 312,027 | - | - | Jan 31, 2024 |
| BRIDGEWAY FUNDS INC | 0.12% | 275,700 | 105,500 | 61.99% | Mar 28, 2024 |
| BlackRock Advantage SMID Cap Fund, Inc. | 0.11% | 20,383 | - | - | Mar 28, 2024 |
| VANGUARD VALLEY FORGE FUNDS | 0.09% | 49,072 | - | - | Mar 31, 2024 |
| TEKLA HEALTHCARE INVESTORS | 0.08% | 69,389 | - | - | Mar 31, 2024 |
| TEKLA LIFE SCIENCES INVESTORS | 0.06% | 28,965 | - | - | Mar 31, 2024 |
| PRUDENTIAL SECTOR FUNDS, INC. | 0.06% | 119,157 | - | - | Feb 29, 2024 |
| Humankind Benefit Corp | 0.03% | 761 | - | - | Dec 31, 2023 |
| IndexIQ ETF Trust | 0.03% | 69,721 | - | - | Jan 31, 2024 |
| NEUBERGER BERMAN EQUITY FUNDS | 0.02% | 197,275 | - | - | Feb 29, 2024 |
| QUANTITATIVE MASTER SERIES LLC | 0.02% | 103,661 | - | - | Mar 31, 2024 |
| DEUTSCHE DWS INVESTMENTS VIT FUNDS | 0.02% | 9,364 | - | - | Mar 31, 2024 |
| GOLDMAN SACHS VARIABLE INSURANCE TRUST | 0.01% | 36,762 | -8,777 | -19.27% | Mar 31, 2024 |
| ETFis Series Trust I | 0.01% | 10,670 | - | - | Jan 31, 2024 |
| Fidelity Commonwealth Trust II | 0.01% | 49,542 | - | - | Aug 31, 2023 |
| VANGUARD EXPLORER FUND | 0.01% | 84,721 | - | - | Jan 31, 2024 |
| VANGUARD INDEX FUNDS | 0.01% | 2,617,256 | -681,056 | -20.65% | Mar 31, 2024 |
| TIAA SEPARATE ACCOUNT VA 1 | 0.01% | 1,211 | - | - | Mar 31, 2024 |
| FIDELITY SELECT PORTFOLIOS | 0.00% | 304,500 | - | - | Feb 29, 2024 |
| VARIABLE INSURANCE PRODUCTS FUND II | 0.00% | 57,460 | 27,534 | 92.01% | Mar 31, 2024 |
| Nushares ETF Trust | 0.00% | 30,226 | - | - | Jan 31, 2024 |
| SCHWAB CAPITAL TRUST | 0.00% | 160,876 | - | - | Jan 31, 2024 |
| FIDELITY COVINGTON TRUST | 0.00% | 48,975 | -567 | -1.14% | Mar 31, 2024 |
| FIDELITY CONCORD STREET TRUST | 0.00% | 500,278 | 37,083 | 8.01% | Feb 29, 2024 |
| Simplify Exchange Traded Funds | 0.00% | 120,000 | - | - | Mar 28, 2024 |
| ETF Series Solutions | 0.00% | 42,187 | 6,761 | 19.08% | Feb 29, 2024 |
| Calvert Variable Products, Inc. | 0.00% | 4,967 | - | - | Mar 31, 2024 |
| AMG Funds I | 0.00% | 3,485 | - | - | Jan 31, 2024 |
| NATIONWIDE VARIABLE INSURANCE TRUST | 0.00% | 234,564 | -3,845 | -1.61% | Mar 31, 2024 |
| PFM Multi-Manager Series Trust | 0.00% | 1,409 | - | - | Dec 31, 2023 |
| Direxion Shares ETF Trust | 0.00% | 220,371 | - | - | Jan 31, 2024 |
| Legg Mason ETF Investment Trust | 0.00% | 2,851 | - | - | Mar 31, 2024 |
| VANGUARD INSTITUTIONAL INDEX FUNDS | 0.00% | 38,073 | -2,802 | -6.86% | Mar 31, 2024 |
| MFS VARIABLE INSURANCE TRUST III | 0.00% | 20,182 | - | - | Mar 31, 2024 |
| PUTNAM ASSET ALLOCATION FUNDS | 0.00% | 32,717 | - | - | Mar 31, 2024 |
| Dimensional ETF Trust | 0.00% | 443,685 | 110,462 | 33.15% | Jan 31, 2024 |
| Principal Exchange-Traded Funds | 0.00% | 11,598 | -731 | -5.93% | Mar 31, 2024 |
| North Square Investments Trust | 0.00% | 9,140 | - | - | Jan 31, 2024 |
| DRIEHAUS MUTUAL FUNDS | 0.00% | 8,054 | - | - | Mar 28, 2024 |
| Managed Portfolio Series | 0.00% | 18,563 | - | - | Mar 31, 2024 |
| Virtus Investment Trust | 0.00% | 28,274 | - | - | Mar 28, 2024 |
| OHIO NATIONAL FUND INC | 0.00% | 13,219 | - | - | Mar 31, 2024 |
| MUTUAL FUND SERIES TRUST | 0.00% | 2,708,975 | - | - | Mar 31, 2024 |
| Voya VARIABLE PORTFOLIOS INC | 0.00% | 20,055 | -5,966 | -22.93% | Mar 31, 2024 |
| HC CAPITAL TRUST | 0.00% | 19,747 | - | - | Mar 31, 2024 |
| DFA INVESTMENT DIMENSIONS GROUP INC | 0.00% | 587,358 | -46,859 | -7.39% | Jan 31, 2024 |
| INVESCO EXCHANGE-TRADED FUND TRUST | 0.00% | 44,255 | - | - | Jan 31, 2024 |
| STATE STREET VARIABLE INSURANCE SERIES FUNDS INC | 0.00% | 2,601 | -853 | -24.70% | Mar 31, 2024 |
| Meeder Funds | 0.00% | 2,555 | - | - | Mar 31, 2024 |
| PRUDENTIAL INVESTMENT PORTFOLIOS, INC. | 0.00% | 5,000 | - | - | Mar 28, 2024 |
| AMG FUNDS III | 0.00% | 2,670 | - | - | Mar 28, 2024 |
| AdvisorShares Trust | 0.00% | 1,832 | - | - | Mar 28, 2024 |
| AMERICAN CENTURY ETF TRUST | 0.00% | 48,941 | 6,046 | 14.09% | Feb 29, 2024 |
| VANGUARD WORLD FUND | 0.00% | 104,979 | - | - | Feb 29, 2024 |
| BAILLIE GIFFORD FUNDS | 0.00% | 4,387 | 223 | 5.36% | Mar 28, 2024 |
| SunAmerica Specialty Series | 0.00% | 214 | - | - | Apr 30, 2021 |
| STATE STREET INSTITUTIONAL INVESTMENT TRUST | 0.00% | 20,000 | - | - | Mar 31, 2024 |
| VANGUARD VARIABLE INSURANCE FUNDS | 0.00% | 15,437 | - | - | Mar 31, 2024 |
| TIAA-CREF LIFE FUNDS | 0.00% | 730 | - | - | Mar 31, 2024 |
| GLENMEDE FUND INC | 0.00% | 2,228 | - | - | Jan 31, 2024 |
| LOOMIS SAYLES FUNDS II | 0.00% | 669,530 | - | - | Mar 31, 2024 |
| LAZARD FUNDS INC | 0.00% | 9,014 | - | - | Mar 31, 2024 |
| GPS Funds I | 0.00% | 1,113 | - | - | Mar 31, 2024 |
| OLD WESTBURY FUNDS INC | 0.00% | 26,609 | - | - | Jan 31, 2024 |
| NORTHERN FUNDS | 0.00% | 27,332 | -2,557 | -8.55% | Mar 28, 2024 |
| T. Rowe Price Index Trust, Inc. | 0.00% | 3,752 | - | - | Mar 31, 2024 |
| GOLDMAN SACHS TRUST | 0.00% | 587,791 | -48,312 | -7.59% | Jan 31, 2024 |
| JPMORGAN INSURANCE TRUST | 0.00% | 2,001 | -99 | -4.71% | Mar 31, 2023 |
| EQ ADVISORS TRUST | 0.00% | 184,032 | 16 | 0.01% | Mar 31, 2024 |
| iSHARES TRUST | 0.00% | 2,331,233 | -132,117 | -5.36% | Mar 31, 2024 |
| MASTER INVESTMENT PORTFOLIO | 0.00% | 11,819 | - | - | Mar 31, 2024 |
| VANGUARD SCOTTSDALE FUNDS | 0.00% | 263,329 | 29,734 | 12.73% | Feb 29, 2024 |
| RYDEX SERIES FUNDS | 0.00% | 549 | - | - | Dec 31, 2023 |
| Columbia Funds Variable Series Trust II | 0.00% | 4,136 | - | - | Mar 31, 2024 |
| COLLEGE RETIREMENT EQUITIES FUND | 0.00% | 137,743 | 121,900 | 769.42% | Mar 31, 2024 |
| RBB FUND, INC. | 0.00% | 11,415 | - | - | Feb 29, 2024 |
| VICTORY PORTFOLIOS | 0.00% | 3,661 | - | - | Mar 31, 2024 |
| Federated Hermes Global Allocation Fund | 0.00% | 916 | - | - | Feb 29, 2024 |
| Guggenheim Active Allocation Fund | 0.00% | 517 | - | - | Feb 29, 2024 |
| RUSSELL INVESTMENT CO | 0.00% | 24,647 | 15,901 | 181.81% | Jan 31, 2024 |
| Blackstone Alternative Investment Funds | 0.00% | 9,800 | 5,600 | 133.33% | Mar 31, 2024 |
| VALIC Co I | 0.00% | 23,082 | -93 | -0.40% | Feb 29, 2024 |
| PENN SERIES FUNDS INC | 0.00% | 2,134 | - | - | Mar 28, 2024 |
| Goldman Sachs ETF Trust | 0.00% | 6,791 | - | - | Feb 29, 2024 |
| RYDEX DYNAMIC FUNDS | 0.00% | 272 | - | - | Dec 31, 2023 |
| TIAA-CREF FUNDS | 0.00% | 194,361 | - | - | Jan 31, 2024 |
| SA FUNDS INVESTMENT TRUST | 0.00% | 908 | - | - | Mar 31, 2024 |
| RUSSELL INVESTMENT FUNDS | 0.00% | 6,281 | 2,976 | 90.05% | Mar 31, 2024 |
| SPDR SERIES TRUST | 0.00% | 1,999,864 | - | - | Mar 31, 2024 |
| NATIONWIDE MUTUAL FUNDS | 0.00% | 6,700 | 914 | 15.80% | Jan 31, 2024 |
| PACE SELECT ADVISORS TRUST | 0.00% | 14,119 | - | - | Jan 31, 2024 |
| FLEXSHARES TRUST | 0.00% | 3,384 | - | - | Jan 31, 2024 |
| Invesco Exchange-Traded Fund Trust II | 0.00% | 12,605 | 4,596 | 57.39% | Feb 29, 2024 |
| ProFunds | 0.00% | 473 | -33 | -6.52% | Mar 31, 2024 |
| Voya INVESTORS TRUST | 0.00% | 2,174 | -162 | -6.93% | Mar 31, 2024 |
| LoCorr Investment Trust | 0.00% | 989 | - | - | Mar 31, 2024 |
| PROSHARES TRUST | 0.00% | 8,813 | -2,814 | -24.20% | Feb 29, 2024 |
| ALLIANZ VARIABLE INSURANCE PRODUCTS TRUST | 0.00% | 1,873 | - | - | Dec 31, 2023 |
Sutro Biopharma's largest mutual fund holder by % of total assets is "CORNERCAP GROUP OF FUNDS /VA/", owning 18.56K shares, compromising 0.26% of its total assets.
Sutro Biopharma Institutional Ownership Trends
Institutional Holdings Trend
| Date | Holdings | Change % |
|---|---|---|
| 30 Jun, 24 | 122 | 3.39% |
| 31 Mar, 24 | 118 | 3.51% |
| 31 Dec, 23 | 114 | 3.64% |
| 30 Sep, 23 | 110 | -9.09% |
| 30 Jun, 23 | 121 | 4.31% |
| 31 Mar, 23 | 116 | -3.33% |
| 31 Dec, 22 | 120 | 7.14% |
| 30 Sep, 22 | 112 | -4.27% |
| 30 Jun, 22 | 117 | 1.74% |
| 31 Mar, 22 | 115 | -2.54% |
| 31 Dec, 21 | 118 | -2.48% |
| 30 Sep, 21 | 121 | -3.20% |
| 30 Jun, 21 | 125 | -14.38% |
| 31 Mar, 21 | 146 | 8.15% |
| 31 Dec, 20 | 135 | 58.82% |
| 30 Sep, 20 | 85 | 8.97% |
| 30 Jun, 20 | 78 | 30.00% |
| 31 Mar, 20 | 60 | -6.25% |
| 31 Dec, 19 | 64 | 8.47% |
| 30 Sep, 19 | 59 | - |
| 30 Jun, 19 | 59 | 20.41% |
| 31 Mar, 19 | 49 | 13.95% |
| 31 Dec, 18 | 43 | 30.30% |
| 30 Sep, 18 | 33 | - |
As of 30 Jun 24, 122 institutions are holding Sutro Biopharma's shares, representing an increase of 3.39% compared to the previous quarter.
Shares Outstanding Trend
| Date | Shares Outstanding | Change % |
|---|---|---|
| 30 Jun, 24 | 63,167,394 | 18.26% |
| 31 Mar, 24 | 53,412,278 | -3.97% |
| 31 Dec, 23 | 55,621,581 | -0.54% |
| 30 Sep, 23 | 55,925,507 | 3.50% |
| 30 Jun, 23 | 54,032,251 | 0.72% |
| 31 Mar, 23 | 53,648,061 | 7.54% |
| 31 Dec, 22 | 49,887,257 | -0.97% |
| 30 Sep, 22 | 50,377,400 | 8.93% |
| 30 Jun, 22 | 46,246,652 | 10.73% |
| 31 Mar, 22 | 41,764,499 | 4.81% |
| 31 Dec, 21 | 39,848,108 | 0.12% |
| 30 Sep, 21 | 39,800,854 | -3.38% |
| 30 Jun, 21 | 41,193,137 | -7.10% |
| 31 Mar, 21 | 44,339,884 | 12.74% |
| 31 Dec, 20 | 39,329,278 | 28.91% |
| 30 Sep, 20 | 30,509,637 | 25.23% |
| 30 Jun, 20 | 24,363,818 | 105.28% |
| 31 Mar, 20 | 11,868,856 | 2.17% |
| 31 Dec, 19 | 11,616,463 | 4.89% |
| 30 Sep, 19 | 11,074,628 | -6.29% |
| 30 Jun, 19 | 11,817,506 | 5.21% |
| 31 Mar, 19 | 11,231,814 | 3.52% |
| 31 Dec, 18 | 10,849,691 | 17.50% |
| 30 Sep, 18 | 9,233,528 | - |
Sutro Biopharma (STRO) has 63.17M shares outstanding as of 30 Jun 24, up 18.26% compared to the previous quarter.
Institutional Ownership Trend
| Date | Ownership % | Change % |
|---|---|---|
| 30 Jun, 24 | 102.78% | 1.34% |
| 31 Mar, 24 | 87.55% | 1.04% |
| 31 Dec, 23 | 91.79% | 1.07% |
| 30 Sep, 23 | 92.68% | 1.09% |
| 30 Jun, 23 | 92.01% | 1.10% |
| 31 Mar, 23 | 91.36% | 0.95% |
| 31 Dec, 22 | 98.32% | 1.06% |
| 30 Sep, 22 | 96.24% | 0.99% |
| 30 Jun, 22 | 98.49% | 1.22% |
| 31 Mar, 22 | 89.82% | 1.21% |
| 31 Dec, 21 | 86.32% | 1.16% |
| 30 Sep, 21 | 86.22% | 1.08% |
| 30 Jun, 21 | 89.32% | 0.96% |
| 31 Mar, 21 | 96.59% | 0.85% |
| 31 Dec, 20 | 106.62% | 1.56% |
| 30 Sep, 20 | 82.71% | 1.25% |
| 30 Jun, 20 | 81.48% | 3.11% |
| 31 Mar, 20 | 51.16% | 2.04% |
| 31 Dec, 19 | 50.08% | 2.15% |
| 30 Sep, 19 | 48.26% | 1.82% |
| 30 Jun, 19 | 51.55% | 2.14% |
| 31 Mar, 19 | 49.12% | 2.18% |
| 31 Dec, 18 | 47.45% | 2.90% |
| 30 Sep, 18 | 40.46% | - |
As of 30 Jun 24, Sutro Biopharma is held by 102.78% institutional shareholders, representing a 1.34% growth compared to 31 Mar 24.
Institutional Increased Positions Trend
| Date | Increased Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 78 | 14.71% |
| 31 Mar, 24 | 68 | 11.48% |
| 31 Dec, 23 | 61 | 22.00% |
| 30 Sep, 23 | 50 | -20.63% |
| 30 Jun, 23 | 63 | -7.35% |
| 31 Mar, 23 | 68 | -6.85% |
| 31 Dec, 22 | 73 | 21.67% |
| 30 Sep, 22 | 60 | -9.09% |
| 30 Jun, 22 | 66 | 1.54% |
| 31 Mar, 22 | 65 | 8.33% |
| 31 Dec, 21 | 60 | 5.26% |
| 30 Sep, 21 | 57 | -9.52% |
| 30 Jun, 21 | 63 | -27.59% |
| 31 Mar, 21 | 87 | -17.92% |
| 31 Dec, 20 | 106 | 85.96% |
| 30 Sep, 20 | 57 | - |
| 30 Jun, 20 | 57 | 83.87% |
| 31 Mar, 20 | 31 | -16.22% |
| 31 Dec, 19 | 37 | 23.33% |
| 30 Sep, 19 | 30 | -6.25% |
| 30 Jun, 19 | 32 | 28.00% |
| 31 Mar, 19 | 25 | -16.67% |
| 31 Dec, 18 | 30 | -9.09% |
| 30 Sep, 18 | 33 | - |
78 institutional shareholders have increased their position in STRO stock as of 30 Jun 24 compared to 68 in the previous quarter (a 14.71% increase).
Institutional Reduced Positions Trend
| Date | Reduced Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 29 | -9.38% |
| 31 Mar, 24 | 32 | 10.34% |
| 31 Dec, 23 | 29 | -9.38% |
| 30 Sep, 23 | 32 | -11.11% |
| 30 Jun, 23 | 36 | 28.57% |
| 31 Mar, 23 | 28 | -3.45% |
| 31 Dec, 22 | 29 | -6.45% |
| 30 Sep, 22 | 31 | 6.90% |
| 30 Jun, 22 | 29 | -17.14% |
| 31 Mar, 22 | 35 | -7.89% |
| 31 Dec, 21 | 38 | 11.76% |
| 30 Sep, 21 | 34 | -19.05% |
| 30 Jun, 21 | 42 | 27.27% |
| 31 Mar, 21 | 33 | 83.33% |
| 31 Dec, 20 | 18 | 12.50% |
| 30 Sep, 20 | 16 | 45.45% |
| 30 Jun, 20 | 11 | -26.67% |
| 31 Mar, 20 | 15 | 66.67% |
| 31 Dec, 19 | 9 | -35.71% |
| 30 Sep, 19 | 14 | -6.67% |
| 30 Jun, 19 | 15 | 50.00% |
| 31 Mar, 19 | 10 | 42.86% |
| 31 Dec, 18 | 7 | - |
| 30 Sep, 18 | - | - |
29 institutional shareholders have reduced their position in STRO stock as of 30 Jun 24 compared to 32 in the previous quarter (a -9.38% decrease).
All Institutional Ownership Trend Data
| Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| 30 Jun, 24 | 122 | 3.39% | 63,167,394 | 18.26% | 102.78% | 1.34% | 78 | 14.71% | 29 | -9.38% |
| 31 Mar, 24 | 118 | 3.51% | 53,412,278 | -3.97% | 87.55% | 1.04% | 68 | 11.48% | 32 | 10.34% |
| 31 Dec, 23 | 114 | 3.64% | 55,621,581 | -0.54% | 91.79% | 1.07% | 61 | 22.00% | 29 | -9.38% |
| 30 Sep, 23 | 110 | -9.09% | 55,925,507 | 3.50% | 92.68% | 1.09% | 50 | -20.63% | 32 | -11.11% |
| 30 Jun, 23 | 121 | 4.31% | 54,032,251 | 0.72% | 92.01% | 1.10% | 63 | -7.35% | 36 | 28.57% |
| 31 Mar, 23 | 116 | -3.33% | 53,648,061 | 7.54% | 91.36% | 0.95% | 68 | -6.85% | 28 | -3.45% |
| 31 Dec, 22 | 120 | 7.14% | 49,887,257 | -0.97% | 98.32% | 1.06% | 73 | 21.67% | 29 | -6.45% |
| 30 Sep, 22 | 112 | -4.27% | 50,377,400 | 8.93% | 96.24% | 0.99% | 60 | -9.09% | 31 | 6.90% |
| 30 Jun, 22 | 117 | 1.74% | 46,246,652 | 10.73% | 98.49% | 1.22% | 66 | 1.54% | 29 | -17.14% |
| 31 Mar, 22 | 115 | -2.54% | 41,764,499 | 4.81% | 89.82% | 1.21% | 65 | 8.33% | 35 | -7.89% |
| 31 Dec, 21 | 118 | -2.48% | 39,848,108 | 0.12% | 86.32% | 1.16% | 60 | 5.26% | 38 | 11.76% |
| 30 Sep, 21 | 121 | -3.20% | 39,800,854 | -3.38% | 86.22% | 1.08% | 57 | -9.52% | 34 | -19.05% |
| 30 Jun, 21 | 125 | -14.38% | 41,193,137 | -7.10% | 89.32% | 0.96% | 63 | -27.59% | 42 | 27.27% |
| 31 Mar, 21 | 146 | 8.15% | 44,339,884 | 12.74% | 96.59% | 0.85% | 87 | -17.92% | 33 | 83.33% |
| 31 Dec, 20 | 135 | 58.82% | 39,329,278 | 28.91% | 106.62% | 1.56% | 106 | 85.96% | 18 | 12.50% |
| 30 Sep, 20 | 85 | 8.97% | 30,509,637 | 25.23% | 82.71% | 1.25% | 57 | - | 16 | 45.45% |
| 30 Jun, 20 | 78 | 30.00% | 24,363,818 | 105.28% | 81.48% | 3.11% | 57 | 83.87% | 11 | -26.67% |
| 31 Mar, 20 | 60 | -6.25% | 11,868,856 | 2.17% | 51.16% | 2.04% | 31 | -16.22% | 15 | 66.67% |
| 31 Dec, 19 | 64 | 8.47% | 11,616,463 | 4.89% | 50.08% | 2.15% | 37 | 23.33% | 9 | -35.71% |
| 30 Sep, 19 | 59 | - | 11,074,628 | -6.29% | 48.26% | 1.82% | 30 | -6.25% | 14 | -6.67% |
| 30 Jun, 19 | 59 | 20.41% | 11,817,506 | 5.21% | 51.55% | 2.14% | 32 | 28.00% | 15 | 50.00% |
| 31 Mar, 19 | 49 | 13.95% | 11,231,814 | 3.52% | 49.12% | 2.18% | 25 | -16.67% | 10 | 42.86% |
| 31 Dec, 18 | 43 | 30.30% | 10,849,691 | 17.50% | 47.45% | 2.90% | 30 | -9.09% | 7 | - |
| 30 Sep, 18 | 33 | - | 9,233,528 | - | 40.46% | - | 33 | - | - | - |
Sutro Biopharma Insider Shareholders Trades
Open Market Insider Trades
| Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
|---|
Open Market Insider Buys
| Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
|---|
Insider Sells
All Insider Owners Trades
The last insider sell of Sutro Biopharma's stock was made by Chung Jane on Aug 13 2024, selling 6,689 shares at $3.12 per share (valued at $20.87K).
Sutro Biopharma Insider Ownership Trends
All Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q3 2024 | 2 | - | - |
| Q2 2024 | 10 | 4 | 250.00% |
| Q1 2024 | 36 | 35 | 102.86% |
| Q4 2023 | 2 | - | - |
| Q3 2023 | 4 | 6 | 66.67% |
| Q2 2023 | 12 | 7 | 171.43% |
| Q1 2023 | 39 | 43 | 90.70% |
| Q3 2022 | 2 | 2 | 100.00% |
| Q2 2022 | 16 | 2 | 800.00% |
| Q1 2022 | 32 | 30 | 106.67% |
| Q4 2021 | 3 | 2 | 150.00% |
| Q3 2021 | 10 | 25 | 40.00% |
| Q2 2021 | 12 | - | - |
| Q1 2021 | 22 | 19 | 115.79% |
| Q4 2020 | 7 | 10 | 70.00% |
| Q3 2020 | 7 | 20 | 35.00% |
| Q2 2020 | 11 | 6 | 183.33% |
| Q1 2020 | 13 | 4 | 325.00% |
| Q4 2019 | - | 3 | - |
| Q3 2019 | 11 | 20 | 55.00% |
2 total buy trades, and 0 total sell trades (buy/sell ratio of 0%) were made by Sutro Biopharma's insiders, as of Q3 2024.
Open Market Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q3 2024 | - | - | - |
| Q2 2024 | - | - | - |
| Q1 2024 | - | 1 | - |
| Q4 2023 | - | - | - |
| Q3 2023 | - | 2 | - |
| Q2 2023 | - | - | - |
| Q1 2023 | - | - | - |
| Q3 2022 | - | - | - |
| Q2 2022 | - | - | - |
| Q1 2022 | 1 | - | - |
| Q4 2021 | - | - | - |
| Q3 2021 | - | 1 | - |
| Q2 2021 | - | - | - |
| Q1 2021 | - | 2 | - |
| Q4 2020 | - | 3 | - |
| Q3 2020 | - | 6 | - |
| Q2 2020 | 3 | 6 | 50.00% |
| Q1 2020 | - | 3 | - |
| Q4 2019 | - | 3 | - |
| Q3 2019 | - | - | - |
As of Q3 2024, Insider owners conducted 0 open market buy trades and 0 open market sell trades of Sutro Biopharma's stocks.
Sutro Biopharma Peer Ownership
| Ticker | Company |
|---|---|
| ANAB | AnaptysBio, Inc. |
| IDYA | IDEAYA Biosciences, Inc. |
| CNTA | Centessa Pharmaceuticals plc |
| MRUS | Merus N.V. |
| LRMR | Larimar Therapeutics, Inc. |
| MLYS | Mineralys Therapeutics, Inc. |
| MGTX | MeiraGTx Holdings plc |
| HLVX | HilleVax, Inc. |
| AVTE | Aerovate Therapeutics, Inc. |
| REPL | Replimune Group, Inc. |
| SNDX | Syndax Pharmaceuticals, Inc. |
| KROS | Keros Therapeutics, Inc. |
| GNTA | Genenta Science S.p.A. |
| PCVX | Vaxcyte, Inc. |
| FIXX | Q32 Bio Inc. |
| PRDS | Pardes Biosciences, Inc. |
| OPT | Opthea Limited |
| ELYM | Eliem Therapeutics, Inc. |
STRO Ownership FAQ
Who Owns Sutro Biopharma?
Sutro Biopharma is owned by institutional shareholders (102.78%), insiders (0.93%), and public (-3.71%). The largest institutional shareholder of Sutro Biopharma is SUVRETTA CAPITAL MANAGEMENT, LLC (12.54% of total shares) and the top mutual fund owner is CORNERCAP GROUP OF FUNDS /VA/ (0.26% of total shares).
Who are the major institutional shareholders of Sutro Biopharma?
Sutro Biopharma's major institutional shareholders are SUVRETTA CAPITAL MANAGEMENT, LLC, BLACKROCK INC., POINT72 ASSET MANAGEMENT, L.P., MILLENNIUM MANAGEMENT LLC, and VANGUARD GROUP INC. The top five shareholders own together 43.91% of the company's share outstanding.
How many Sutro Biopharma shareholders are there?
As of Jun 2024, there are 122 institutional shareholders of Sutro Biopharma.
What percentage of Sutro Biopharma is owned by SUVRETTA CAPITAL MANAGEMENT, LLC?
SUVRETTA CAPITAL MANAGEMENT, LLC owns 7.71M shares of Sutro Biopharma, representing 12.54% of the company's total shares outstanding, valued at $22.59M (as of Jun 2024).
What percentage of Sutro Biopharma is owned by BLACKROCK INC?
As of Jun 2024, BLACKROCK INC holds 6.91M shares of Sutro Biopharma (STRO), compromising 11.24% of the company, valued at $20.25M.
What percentage of Sutro Biopharma is owned by POINT72 ASSET MANAGEMENT, L.P?
POINT72 ASSET MANAGEMENT, L.P is the third largest holder of Sutro Biopharma. The company owns 4.45M of the company's shares outstanding (worth $13.03M).